SEC Form 4 · accession 0001264931-15-000025
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Aronstam
Officer — CHIEF FINANCIAL OFFICER
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 10:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WARRANT (RIGHT TO BUY) | $0.14 | Jan 15, 2015 | A | 250,000 | A | Dec 15, 2014 | Dec 14, 2019 | COMMON STOCK | 250,000 | 250,000 | D |